INDATRALINE

Details

Stereochemistry	RACEMIC
Molecular Formula	C16H15Cl2N
Molecular Weight	292.203
Optical Activity	( + / - )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN[C@@H]1C[C@H](C2=CC=CC=C12)C3=CC(Cl)=C(Cl)C=C3

InChI

InChIKey=SVFXPTLYMIXFRX-XJKSGUPXSA-N

InChI=1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3/t13-,16+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C16H15Cl2N
Molecular Weight	292.203
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10490887 | https://www.ncbi.nlm.nih.gov/pubmed/11889495 | https://www.ncbi.nlm.nih.gov/pubmed/22075572

Indatraline (Lu 19-005) is a non-selective monoamine transporter inhibitor that has been shown to block the reuptake of dopamine, norepinephrine, and serotonin with effects similar to those of cocaine. In vivo, indatraline produced behavioral effects suggestive of enhanced dopaminergic, noradrenergic, and serotonergic activity in mice. Indatraline also substituted for a high dose of cocaine in rats trained to discriminate between a low and a high dose of cocaine, which demonstrates that indatraline produces cocaine-like discriminative stimulus effects. Indatraline has been studied to block the action of methamphetamine and MDMA.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
Dopamine transporter 183 Target ID: CHEMBL238 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11150168	Inhibitor 8504	290.0 nM [Ki]
Serotonin transporter 183 Target ID: CHEMBL228 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11150168	Inhibitor 8504	38.0 nM [Ki]
Norepinephrine transporter 197 Target ID: CHEMBL222 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11150168	Inhibitor 8504	600.0 nM [Ki]

PubMed

Title	Date	PubMed
Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.	2007-04	17234900
Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys.	2001-07	11377924
Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys.	1999-10	10490887
Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.	1985-04	2409454

Patents

Sample Use Guides

In Vivo Use Guide

rhesus monkeys: 0.1–0.56 mg/kg/day

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Wed Apr 02 06:52:44 GMT 2025` Edited by `admin` on `Wed Apr 02 06:52:44 GMT 2025`
Record UNII	4U40Y96J1Z
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

indatraline [INN]

Preferred Name

English

INDATRALINE

Official Name

English

(±)-TRANS-3-(3,4-DICHLOROPHENYL)-N-METHYL-1-INDANAMINE

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C94725